The Analytical Service and Training Laboratory (ASTL) at the Complex Carbohydrate Research Center is requesting funds to purchase a Thermo Scientific Orbitrap Tribrid Fusion mass spectrometer and nano-liquid chromatography system that will be dedicated to glycomics, glycoproteomics and glycosaminoglycan research service projects from a large number of NIH-Investigators from institutes all across the United States. The Orbitrap Fusion at ASTL will have a major impact on many disease related biomedical glycomics projects. This research is significant for muscular dystrophy, HIV vaccine research, heart and lung disease, atherosclerosis and venous thrombo-embolism, cardiac xenotransplantation, Lafora disease, pulmonary fibrosis, anthrax, and many others. The Orbitrap Fusion has unique features such as high sensitivity and resolution, HCD/ETD fragmentation capability, and unprecedented flexibility, which are necessary for all our glycomics and glycoproteomics proposed research projects. Existing LC-MS instrumentation in the facility includes an older LTQ-Orbitrap Discovery, which is not upgradable to ETD/HCD capability and has been discontinued. The number of research groups that will be impacted by the acquisition of the proposed Orbitrap Fusion instrument at the ASTL spans the entire country. Just in the past five years, more than 60 NIH-funded investigators from all over U.S have accessed ASTL's instrumentation and its unique expertise to advance their own carbohydrate research projects. The Orbitrap Fusion will also be utilized in several annual hands-on workshops to train more glycoscientists, and to bring cutting edge mass spectrometry expertise to the larger glycoscience community.
The purchase of this instrument will benefit several scientific groups around the United States in their medical research. The instrument will accelerate studies including, but not limited to, therapies for leukemia and muscular dystrophy, the design of HIV vaccines, blood group factors protecting against heart and lung disease, reducing the rejection of organ transplants, and the economical production of therapeutic glycoproteins.
|Spiciarich, David R; Oh, Stephen T; Foley, Amy et al. (2018) A Novel Germline Variant in CSF3R Reduces N-Glycosylation and Exerts Potent Oncogenic Effects in Leukemia. Cancer Res 78:6762-6770|
|Zhang, Peng; Lu, Hong; Peixoto, Rui T et al. (2018) Heparan Sulfate Organizes Neuronal Synapses through Neurexin Partnerships. Cell 174:1450-1464.e23|
|Borges, Ricardo M; Taujale, Rahil; de Souza, Juliana Santana et al. (2018) Dereplication of plant phenolics using a mass-spectrometry database independent method. Phytochem Anal 29:601-612|
|Tanigaki, Keiji; Sacharidou, Anastasia; Peng, Jun et al. (2018) Hyposialylated IgG activates endothelial IgG receptor Fc?RIIB to promote obesity-induced insulin resistance. J Clin Invest 128:309-322|
|Byrne, Gabriel; O'Rourke, Sara M; Alexander, David L et al. (2018) CRISPR/Cas9 gene editing for the creation of an MGAT1-deficient CHO cell line to control HIV-1 vaccine glycosylation. PLoS Biol 16:e2005817|
|Kolinko, Sebastian; Wu, Yu-Wei; Tachea, Firehiwot et al. (2018) A bacterial pioneer produces cellulase complexes that persist through community succession. Nat Microbiol 3:99-107|
|Chen, Yu; Bensing, Barbara A; Seepersaud, Ravin et al. (2018) Unraveling the sequence of cytosolic reactions in the export of GspB adhesin from Streptococcus gordonii. J Biol Chem 293:5360-5373|
|Zhou, Yihong; Badgett, Majors J; Billard, Lynne et al. (2017) Properties of the cuticular proteins of Anopheles gambiae as revealed by serial extraction of adults. PLoS One 12:e0175423|
|Lowery 3rd, Curtis Lee; Elliott, Clay; Cooper, Anthonya et al. (2017) Cigarette Smoking-Associated Alterations in Serotonin/Adrenalin Signaling Pathways of Platelets. J Am Heart Assoc 6:|
|Amore, Antonella; Knott, Brandon C; Supekar, Nitin T et al. (2017) Distinct roles of N- and O-glycans in cellulase activity and stability. Proc Natl Acad Sci U S A 114:13667-13672|
Showing the most recent 10 out of 17 publications